OPKO HEALTH INC
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
OPK$1.710.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Equity
CONSOLIDATED STATEMENTS OF EQUITY
(In thousands, except share data)
For the three and nine months ended September 30, 2024
| Accumulated | ||||||||
|---|---|---|---|---|---|---|---|---|
| Additional · Other | ||||||||
| Common Stock · Treasury · Paid-In · Comprehensive · Accumulated | ||||||||
| Shares | Dollars | Shares | Dollars | Capital | Loss | Deficit | Total | |
| Balance at June 30, 2024 | 727,176,232 | $7,273 | (29,799,907) | $(1,791) | $3,540,414 | $(46,652) | $(2,103,927) | $1,395,317 |
| Equity-based compensation expense | — | — | — | — | 2,784 | — | — | 2,784 |
| Repurchase of 2029 Convertible Notes | — | — | — | — | (2,853) | — | — | (2,853) |
| Share repurchase | (14,893,026) | (149) | — | — | (23,610) | — | — | (23,759) |
| Net income | — | — | — | — | — | — | 24,890 | 24,890 |
| Other comprehensive income | — | — | — | — | — | 7,038 | — | 7,038 |
| Balance at September 30, 2024 | 712,283,206 | $7,124 | (29,799,907) | $(1,791) | $3,516,735 | $(39,614) | $(2,079,037) | $1,403,417 |
| Accumulated | ||||||||
|---|---|---|---|---|---|---|---|---|
| Additional · Other | ||||||||
| Common Stock · Treasury · Paid-In · Comprehensive · Accumulated | ||||||||
| Shares | Dollars | Shares | Dollars | Capital | Loss | Deficit | Total | |
| Balance at December 31, 2023 | 781,936,885 | $7,820 | (8,655,082) | $(1,791) | $3,433,006 | $(38,030) | $(2,011,786) | $1,389,219 |
| Equity-based compensation expense | — | — | — | — | 7,983 | — | — | 7,983 |
| Exercise of common stock options and warrants | 384,378 | 4 | — | — | (212) | — | — | (208) |
| 2025 Notes | — | — | (21,144,825) | — | — | — | — | — |
| 2029 Convertible Notes | — | — | — | — | 151,870 | — | — | 151,870 |
| Repurchase of 2029 Convertible Notes | — | — | — | — | (2,853) | — | — | (2,853) |
| Share repurchase | (70,038,057) | (700) | — | — | (73,059) | — | — | (73,759) |
| Net loss | — | — | — | — | — | — | (67,251) | (67,251) |
| Other comprehensive loss | — | — | — | — | — | (1,584) | — | (1,584) |
| Balance at September 30, 2024 | 712,283,206 | $7,124 | (29,799,907) | $(1,791) | $3,516,735 | $(39,614) | $(2,079,037) | $1,403,417 |
CONSOLIDATED STATEMENTS OF EQUITY
(In thousands, except share data)
For the three and nine months ended September 30, 2023
| Accumulated | ||||||||
|---|---|---|---|---|---|---|---|---|
| Additional · Other | ||||||||
| Common Stock · Treasury · Paid-In · Comprehensive · Accumulated | ||||||||
| Shares | Dollars | Shares | Dollars | Capital | Loss | Deficit | Total | |
| Balance at June 30, 2023 | 781,693,135 | $7,817 | (8,655,082) | $(1,791) | $3,427,094 | $(36,942) | $(1,860,830) | $1,535,348 |
| Equity-based compensation expense | — | — | — | — | 3,218 | — | — | 3,218 |
| Exercise of common stock options and warrants | 18,750 | — | — | — | 28 | — | — | 28 |
| Net loss | — | — | — | — | — | — | (84,473) | (84,473) |
| Other comprehensive loss | — | — | — | — | — | (9,553) | — | (9,553) |
| Balance at September 30, 2023 | 781,711,885 | $7,817 | (8,655,082) | $(1,791) | $3,430,340 | $(46,495) | $(1,945,303) | $1,444,568 |
| Accumulated | ||||||||
|---|---|---|---|---|---|---|---|---|
| Additional · Other | ||||||||
| Common Stock · Treasury · Paid-In · Comprehensive · Accumulated | ||||||||
| Shares | Dollars | Shares | Dollars | Capital | Loss | Deficit | Total | |
| Balance at December 31, 2022 | 781,306,164 | $7,813 | (8,655,082) | $(1,791) | $3,421,872 | $(43,323) | $(1,822,923) | $1,561,648 |
| Equity-based compensation expense | — | — | — | — | 8,745 | — | — | 8,745 |
| Exercise of common stock options and warrants | 405,721 | 4 | — | — | (277) | — | — | (273) |
| Net loss | — | — | — | — | — | — | (122,380) | (122,380) |
| Other comprehensive loss | — | — | — | — | — | (3,172) | — | (3,172) |
| Balance at September 30, 2023 | 781,711,885 | $7,817 | (8,655,082) | $(1,791) | $3,430,340 | $(46,495) | $(1,945,303) | $1,444,568 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.